Johnson & Johnson (JNJ) Change in Receivables (2009 - 2026)

Johnson & Johnson (JNJ) posted Change in Receivables of $595.0 million for Q1 2026, up 252.17% sequentially from -$391.0 million in Q4 2025, and down 35.75% YoY from $926.0 million in Q1 2025.

Johnson & Johnson (JNJ) Change in Receivables (2009 - 2026) Analysis & Trends

Johnson & Johnson (JNJ) has 18 years of Change in Receivables data on file, last reported at $595.0 million in Q1 2026.

  • Quarterly Change in Receivables fell 35.75% year-over-year to $595.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 billion (up 37.7% YoY) and the FY2025 annual result came in at $1.8 billion, up 338.67% from the prior year.
  • Change in Receivables climbed to $595.0 million in Q1 2026 per JNJ's latest filing, from -$391.0 million in the prior quarter.
  • The five-year high for Change in Receivables was $1.4 billion in Q2 2025, with the low at -$853.0 million in Q4 2024.
  • Average Change in Receivables over 5 years is $220.3 million, with a median of $252.0 million recorded in 2023.
  • The widest YoY moves for Change in Receivables: up 416.67% in 2024, down 275.77% in 2024.
  • Johnson & Johnson's Change in Receivables stood at $427.0 million in 2022, then plunged by 153.16% to -$227.0 million in 2023, then tumbled by 275.77% to -$853.0 million in 2024, then surged by 54.16% to -$391.0 million in 2025, then soared by 252.17% to $595.0 million in 2026.
  • Business Quant data shows JNJ's Change in Receivables at $595.0 million in Q1 2026, -$391.0 million in Q4 2025, and -$111.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 595.00 Mn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -87.00 Mn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -413.00 Mn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -134.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn -103.40 Mn

Historic Data

Download Data
DateValue
Mar 29, 2026 595.00 Mn
Mar 29, 2026 595.00 Mn
Dec 28, 2025 -391.00 Mn
Dec 28, 2025 -391.00 Mn
Sep 28, 2025 -111.00 Mn
Sep 28, 2025 -111.00 Mn
Jun 29, 2025 1.36 Bn
Jun 29, 2025 1.36 Bn
Mar 30, 2025 926.00 Mn
Mar 30, 2025 926.00 Mn
Dec 29, 2024 -853.00 Mn
Dec 29, 2024 -853.00 Mn
Sep 29, 2024 96.00 Mn
Sep 29, 2024 96.00 Mn
Jun 30, 2024 884.00 Mn
Jun 30, 2024 884.00 Mn
Mar 31, 2024 279.00 Mn
Mar 31, 2024 279.00 Mn
Dec 31, 2023 -227.00 Mn
Dec 31, 2023 -227.00 Mn